Ongoing Developments in Biologic Therapy



Summary

Long-Term Safety of Biologics for Psoriasis Treatment

Safety Data on Biologics Derived From RA Patients

Long-Term Safety of Anti-TNF Agents in Psoriasis Treatment

Long-Term Safety of T-Cell Agents in Psoriasis Treatment

Considerations When Using Biologics

Conclusion

References

Ongoing Developments in Biologic Therapy


Registration benefits include:
Access to CME/CE programs and certification
Free subscription to Biologic Bulletin newsletter
Reminders of new CME/CE activities
REGISTER NOW

Expert Practice: Update on the Long-Term Safety of Biologic Agents for Psoriasis
Update on the Long-Term Safety of Biologic Agents for Psoriasis

Release date: November 2007
Expiration date: November 30, 2008

Estimated time to complete activity: 30 minutes

Sponsored by Curatio CME Institute

Support for this activity has been provided through an educational grant from Genentech, Inc.

Activity Overview
The use of biologics to treat psoriasis is increasing with each passing year. Although the efficacy of biologics has been established, investigation of the long-term safety of these agents is only starting. In this Expert Practice, Dr. Bruce Strober of the Dermatopharmacology Unit at the New York University School of Medicine discusses current data on the long-term safety of the biologics used to treat psoriasis.

Target Audience
This activity has been designed to meet the educational needs of dermatologists and other health care professionals involved in the care of patients with psoriasis.

Learning Objectives
Upon completion of this activity, participants should be able to:
  • Identify the major long-term safety issues associated with biologics used to treat psoriasis
  • Discuss relevant clinical data on safety of biologic agents used for psoriasis
  • Describe recommendations for monitoring safety in patients on biologic agents

Faculty
Bruce Strober, MD, PhD
Assistant Professor and Associate Director
Dermatopharmacology Unit
New York University School of Medicine
New York, New York

Accreditation Statement
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
Curatio CME Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period November 2007 to November 30, 2008, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section.

Media
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

Disclosure
In accordance with the ACCME’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:

Bruce Strober, MD, PhD, has disclosed the following relevant financial relationships:

Speaker/Consultant:      Abbott, Amgen, Astellas, Genentech

Dr. Strober discusses the unlabeled or investigational use of a commercial product.

Curatio CME Institute

Shari J. Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.

Thomas F. Finnegan, PhD, Medical Writer, has disclosed no relevant financial relationships.

Brett Mutschler, CME Director, has disclosed no relevant financial relationships.

Lauren Showers, Program Coordinator, has disclosed no relevant financial relationships.

Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.

Disclaimer
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Genentech, Inc. do not recommend the use of any agent outside the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute or Genentech, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hardware/Software Requirements

  • Version 5.0 or higher for Microsoft Internet Explorer or Netscape 6 or higher
  • If you are using a Mac computer system and are experiencing problems with your browser, we suggest downloading the latest version of Firefox for Mac
Contact Information
PsoriasisTx
100 Campbell Boulevard
Suite 103
Exton, PA 19341
editor@psoriasistx.com

Policy on Privacy and Confidentiality
Curatio CME Institute makes every effort to protect the privacy of PsoriasisTx users; user information is used only to maintain records as required by the American Medical Association (AMA) and the Accreditation Council for Continuing Medical Education (ACCME).

Curatio CME Institute does not require individuals to register to use PsoriasisTx; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on PsoriasisTx.

Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user’s original certificate is lost or misplaced.

Information gathered through PsoriasisTx will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be destroyed.

Curatio CME Institute uses Web site tracking software to determine how PsoriasisTx is used. This information helps Curatio determine the best strategies for improving PsoriasisTx and better meeting the needs of its users. This software does not identify individual users.

PsoriasisTx does not employ cookies or any other software that violates a user's privacy.

If you have any questions about PsoriasisTx or any Curatio CME Institute policies, you may contact us at editor@psoriasistx.com.

Thank you for using PsoriasisTx.




Begin CME Activity